Fulcrum Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,942
Closed -$11.6M 255
2025
Q1
$11.6M Buy
+31,942
New +$12.8M 2.25% 8

Other funds holding ELV

Fulcrum Asset Management's ELV Position: Q1 2026 in Review

Fulcrum Asset Management increased its Elevance Health (ELV) stake by 8.7% in Q1 2026, buying an estimated $136K and bringing the position to 5,195 shares worth $1.48M. The position accounts for 0.22% of the portfolio, ranked #89.

Fulcrum Asset Management first reported a position in ELV in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.92M in Q2 2025. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Fulcrum Asset Management held 5,195 shares of Elevance Health worth $1.48M as of Q1 2026.
  • Fulcrum Asset Management bought 415 Elevance Health shares in Q1 2026, an estimated $136K.
  • Elevance Health made up 0.22% of Fulcrum Asset Management's portfolio in Q1 2026, its #89 holding.
  • Fulcrum Asset Management first reported a position in Elevance Health in Q2 2025 and has held it in 4 quarters since.
  • Fulcrum Asset Management's Elevance Health position peaked at $2.92M in Q2 2025.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.